Quantcast

Latest Biomarker Stories

2014-09-17 12:27:05

New multi-year grant furthers non-profit organization's work to accelerate the drug development process TUCSON, Ariz., Sept. 17, 2014 /PRNewswire-USNewswire/ -- The Critical Path Institute (C-Path) announced today that the U.S. Food and Drug Administration (FDA) has awarded the organization $2.1 million in first year funding of a five-year grant with the potential of $10.5 million over the five years. This is the second five-year grant that C-Path has received from the FDA under the...

2014-09-17 08:29:26

- Phase 2 Clinical Results Show Positive Trends in Slowing Advancement of Disease - PALO ALTO, Calif., Sept. 17, 2014 /PRNewswire/ -- Neuraltus Pharmaceuticals, Inc. announced today that promising efficacy results of the Company's Phase 2 clinical program of NP001 for the treatment of amyotrophic lateral sclerosis (ALS, or Lou Gehrig's disease) are being highlighted today in an oral presentation at the inaugural Summit of the ALS Research Group, being held in Bloomington,...

2014-09-17 08:28:48

IBM Technical Computing & Software Defined Storage Technology Manages Growing Scale and Diversity of Molecular Profiling Data in Cancer Care ARMONK, N.Y., Sept. 17 2014 /PRNewswire/ -- IBM (NYSE: IBM) today announced that Caris Life Sciences is using IBM technical computing and storage technology to accelerate the company's molecular profiling services for cancer patients. These services deliver critically important information to help oncologists develop tailored therapeutic plans...

2014-09-15 23:01:51

Studies conducted by the non-profit Institute of BioAcoustic Biology, located in Albany, Ohio, USA, have consistently demonstrated that math can be much more than a measurement tool; math, as a frequency matrix, can serve as the template to perceive and manage health and wellness. http://www.JournalofBioAcousticBiology.org Albany, Ohio (PRWEB) September 15, 2014 In order to provide predictability and safety, the concepts of math and medicine often act conjointly to quantify, define and...

2014-09-09 08:30:45

WASHINGTON, Sept. 9, 2014 /PRNewswire/ -- Gentag, Inc. is pleased to announce that it has been granted a new, additional allowance for its patents in Europe. This allowance, granted by the European Patent Office, further enhances the company's already significant intellectual property holdings of near field communication (NFC) mobile phone sensor technologies and complements its disposable wearable NFC sensor patent portfolio. The new patent covers quantitative diagnostic tests that...

2014-09-03 23:12:42

The webinar, in partnership with Asuragen, will be presented live September 10, 2014 1:00pm Eastern Time (PRWEB) September 03, 2014 LabRoots announces a new educational webinar for the NGS community. The webinar, titled “NGS Lessons in Translational Diagnostics: Mining and Migrating Robust Cancer Biomarkers to Unified DNA and RNA NGS Panels,” will be airing live September 10, 2014 1:00pm Eastern Time. In this webinar, a comprehensive approach for NGS-based biomarker discovery will...

2014-09-02 08:28:57

PETACH TIKVA, Israel, Sept. 2, 2014 /PRNewswire/ -- Can-Fite BioPharma Ltd. (NYSE MKT: CANF) (TASE: CFBI), a biotechnology company with a pipeline of proprietary small molecule drugs that address inflammatory and cancer diseases, today reported financial results for the six months ended June 30, 2014 and updates on its clinical programs. Clinical and Corporate Highlights Include: -- CF101 - Completes patient enrollment in Phase II/III trial for the treatment of psoriasis...

2014-09-01 12:23:53

DUBLIN, Sept. 1, 2014 /PRNewswire/ -- Research and Markets has announced the addition of the " Early-Stage Minimally-Invasive Biomarkers in Alzheimer's Disease: A Comprehensive Analysis and Market Study of New Developments and Opportunities, 2014" report to their offering. http://photos.prnewswire.com/prnvar/20130307/600769 This report is a comprehensive analysis and market study of new developments relating to early-stage minimally-invasive biomarkers in Alzheimer's disease, which...

2014-08-30 23:01:17

The global metabolomics market is consolidated in nature, wherein the top five players account for more than 70%–75% of the market share. http://www.marketsandmarkets.com/Market-Reports/metabolomics-technology-market-900.html (PRWEB) August 30, 2014 The “Metabolomics Market by Technique (Gas Chromatography, High Performance Liquid Chromatography, Nuclear Magnetic Resonance Spectroscopy, Mass Spectrometry, by Application (Biomarker & Drug Discovery, Nutrigenomics), by Indication...

2014-08-27 12:30:09

Testing for the protein 14-3-3eta may improve the diagnosis of RA, including in early stages when treatment is most likely to improve outcomes MADISON, N.J., Aug. 27, 2014 /PRNewswire/ -- A novel biomarker for rheumatoid arthritis (RA) has significant potential to help physicians better identify early-stage disease, when treatment can often arrest further disease progression and disability, according to a new study in The Journal of Rheumatology....


Word of the Day
vermicular
  • Like a worm in form or movement; vermiform; tortuous or sinuous; also, writhing or wriggling.
  • Like the track or trace of a worm; appearing as if worm-eaten; vermiculate.
  • Marked with fine, close-set, wavy or tortuous lines of color; vermiculated.
  • A form of rusticated masonry which is so wrought as to appear thickly indented with worm-tracks.
This word ultimately comes from the Latin 'vermis,' worm.
Related